Skip to content

Hims & Hers Health

US · HIMS #1813 by market cap Listed 1970
14.60 -1.42 -8.86%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Company notice
    Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.
    SEC · 2026/6/18
  • Hims & Hers Stock Extends Losses After Earnings Stumble -- Barrons.com
    Barron's · 2026/11/11
  • Rating change
    A Quick Look at Today's Ratings for Hims & Hers Health(HIMS.US), With a Forecast Between $32 to $42
    Market Newswire · 2026/8/12
  • Rating change
    J.P. Morgan Assigns Hims & Hers Stock a 'Hold' Rating. What's Behind the Cautious Stance?
    TipRanks · 2026/9/12
  • Rating change
    BofA Securities Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $32
    Market Newswire · 2026/11/7
  • Rating change
    Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $32
    Market Newswire · 2026/9/11
  • Rating change
    Barclays Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $35
    Market Newswire · 2026/10/29
  • Company notice
    Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Director Cosgrove Delos M.
    SEC · 2026/6/16
  • A Quick Look at Today's Ratings for Hims & Hers Health(HIMS.US), With a Forecast Between $24 to $40
    Market Newswire · 2026/11/11
  • Rating change
    Citi Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $33
    Market Newswire · 2026/8/13
  • Hims & Hers Health projects full-year revenue of $3.13 billion to $3.15 billion, below the estimated $3.21 billion.
    Gelonghui Finance · 2026/11/10
  • KeyBanc Maintains Hims & Hers Health(HIMS.US) With Hold Rating
    Market Newswire · 2026/11/12
  • Rating change
    J.P. Morgan Initiates Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $32
    Market Newswire · 2026/9/11
  • Company notice
    8-K: Hims & Hers Health | 8-K: Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
    SEC · 2026/5/12
  • Rating change
    Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $32
    Market Newswire · 2026/8/25
  • Company notice
    Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.
    SEC · 2026/6/16
  • Company notice
    Hims & Hers Health | 8-K: Hims & Hers Health, Inc. Reports Third Quarter 2026 Financial Results
    SEC · 2026/11/10
  • Rating change
    Barclays Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Cuts Target Price to $35
    Market Newswire · 2026/8/21
  • Rating change
    Jefferies Initiates Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $31
    Market Newswire · 2026/9/3
  • BofA Securities Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $32
    Market Newswire · 2026/10/29
  • Rating change
    BofA Securities Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $30
    Market Newswire · 2026/7/30
  • Company notice
    Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.
    SEC · 2026/3/18
  • Without scientific evidence, it first went viral on social media: a loosening of regulations on peptide products—dubbed the "miracle drugs" of the bodybuilding community—has been sent to the White House for review, sending Hims & Hers shares up nearly 6% in a single day.
    Zhitong Finance · 2026/10/16
  • Rating change
    KeyBanc Maintains Hims & Hers Health(HIMS.US) With Hold Rating
    Market Newswire · 2026/9/2
  • Rating change
    Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating
    Market Newswire · 2026/8/10

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.

Hims & Hers Health discussion 0 comments

Add a comment